Psychotic Disorders - Lithuania | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$9.57m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.83%, resulting in a market volume of US$10.48m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$412.10 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Lithuania is experiencing steady growth due to increasing customer preferences for effective treatment options and the rising awareness of mental health issues in the country.

Customer preferences: Customers in Lithuania are increasingly seeking effective treatment options for psychotic disorders. They are looking for medications that can effectively manage symptoms such as hallucinations, delusions, and disorganized thinking. Additionally, customers prefer treatment options that have minimal side effects and provide long-term relief. This preference for effective and safe treatment options is driving the demand for innovative medications in the Psychotic Disorders market.

Trends in the market: One of the major trends in the Psychotic Disorders market in Lithuania is the growing adoption of atypical antipsychotic medications. These medications have gained popularity due to their efficacy in managing symptoms and their reduced side effects compared to traditional antipsychotics. The market is witnessing the introduction of new atypical antipsychotic drugs, which are being well-received by both healthcare professionals and patients.Another trend in the market is the increasing use of psychotherapy as an adjunctive treatment for psychotic disorders. Psychotherapy, such as cognitive-behavioral therapy, has been shown to be effective in helping individuals manage their symptoms and improve their overall quality of life. As awareness of the benefits of psychotherapy grows, more healthcare providers are incorporating it into their treatment plans, leading to an increased demand for psychotherapy services.

Local special circumstances: Lithuania has a relatively high prevalence of mental health disorders, including psychotic disorders. This has led to increased attention and investment in mental health services by the government and healthcare providers. The government has implemented various initiatives to improve access to mental health services and reduce the stigma associated with mental illnesses. These efforts have contributed to the growth of the Psychotic Disorders market in Lithuania.

Underlying macroeconomic factors: The growing Psychotic Disorders market in Lithuania is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in increased healthcare spending. This has allowed for the expansion of mental health services and the availability of a wider range of treatment options for individuals with psychotic disorders. Additionally, the increasing awareness and understanding of mental health issues in the society have led to a greater demand for specialized healthcare services, including those for psychotic disorders.In conclusion, the Psychotic Disorders market in Lithuania is growing due to increasing customer preferences for effective treatment options, the adoption of atypical antipsychotic medications, and the use of psychotherapy as an adjunctive treatment. The local special circumstances, including the high prevalence of mental health disorders and government initiatives to improve mental health services, have also contributed to the market growth. The underlying macroeconomic factors, such as steady economic growth and increased healthcare spending, have further supported the development of the Psychotic Disorders market in Lithuania.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.